| Literature DB >> 26160060 |
Jaroslaw Polanski1, Jacek Bogocz2, Aleksandra Tkocz2.
Abstract
We analyzed a list of the top 100 bestselling drugs as a struggling market for new FDA approvals. Using the time from drug approval by the FDA as a measure of drug age, our analysis showed that the top 100 bestselling drugs are getting older. This reflects the stalled launch of new drugs into the market during recent years.Mesh：
Substances：
Year: 2015 PMID： 26160060 DOI： 10.1016/j.drudis.2015.06.015
Source DB: PubMed Journal: Drug Discov Today ISSN： 1359-6446 Impact factor: 7.851